INS and Stroke: Glucose treatment targets in stroke patients are not clear, and current studies have not found benefit or harm in reducing glucose levels for the first 24 hours using intravenous insulin in stroke patients.23 On the other hand, none of the studies was powered to detect an effect on outcomes, and an ongoing larger study is being conducted.5 The current recommendation is like in most hospitalized patients to aim for glucose levels under 180 mg/dL.